
GAD-65 AntibodyType I Diabetes









The GAD-65 AntibodyType I Diabetes test measures the amount of antibodies that target the glutamic acid decarboxylase (GAD) enzyme in the pancreas and nervous system. These antibodies are linked to the autoimmune response that can cause type 1 diabetes. The test helps diagnose early-stage type 1 diabetes and assess the risk of developing diabetes.








What does GAD-65 AntibodyType I Diabetes measure?
The GAD-65 AntibodyType I Diabetes test measures the presence of antibodies against glutamic acid decarboxylase 65 (GAD-65), an enzyme found in the pancreas and central nervous system. GAD-65 is vital in the production of a neurotransmitter called gamma-aminobutyric acid (GABA) that regulates communication between nerve cells/neurons . GAD antibodies are linked to diabetes, which attacks the cells in the pancreas that make insulin. As the amount of GAD increases, it reduces insulin in the blood, which can lead to diabetes. If not treated, type 1 diabetes can cause serious problems like kidney damage, nerve damage, vision issues, and heart disease.
Furthermore, the presence of antibodies against GAD-65 may also indicate an autoimmune response, where the body’s immune system attacks its own tissues, resulting in autoimmune diseases like Stiff Person Syndrome. A GAD antibody test gives doctors important information about your risk for diabetes and certain autoimmune conditions. The results can help guide the right care and follow up for you.





FAQs related to GAD-65 AntibodyType I Diabetes
- GAD Antibody Test [Internet]. Diabetes.co.uk; 29 Oct. 2023 [Accessed 08 Apr. 2025]. Available from:
- Towns R, Pietropaolo M. GAD65 autoantibodies and its role as biomarker of Type 1 diabetes and Latent Autoimmune Diabetes in Adults (LADA). Drugs Future. 2011 Nov;36(11):847. [Accessed 08 Apr. 2025]. Available from:
- Tridgell DM, Spiekerman C, Wang RS, Greenbaum CJ. Interaction of onset and duration of diabetes on the percent of GAD and IA-2 antibody-positive subjects in the type 1 diabetes genetics consortium database. Diabetes Care. 2011 Apr;34(4):988-93. [Accessed 08 Apr. 2025]. Available from:
- The early detection of type 1 diabetes mellitus and latent autoimmune diabetes in adults (LADA) through rapid test reverse-flow immunochromatography for glutamic acid decarboxylase 65 kDa (GAD65) [Internet]. ScienceDirect; [Accessed 08 Apr. 2025]. Available from:
- Rajkumar V, Levine SN. Latent Autoimmune Diabetes. [Updated 2022 Jun 21]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from:
- Jones AG, McDonald TJ, Shields BM, Hagopian W, Hattersley AT. Latent Autoimmune Diabetes of Adults (LADA) Is Likely to Represent a Mixed Population of Autoimmune (Type 1) and Nonautoimmune (Type 2) Diabetes. Diabetes Care. 2021 Jun;44(6):1243-1251. [Accessed 08 Apr. 2025]. Available from:
- Dade M, Berzero G, Izquierdo C, Giry M, Benazra M, Delattre JY, Psimaras D, Alentorn A. Neurological Syndromes Associated with Anti-GAD Antibodies. Int J Mol Sci. 2020 May 24;21(10):3701. [Accessed 08 Apr. 2025]. Available from:
Other tests
- CBC (Complete Blood Count)
- FBS (Fasting Blood Sugar)
- Thyroid Profile Total (T3, T4 & TSH)
- HbA1c (Glycosylated Hemoglobin)
- PPBS (Postprandial Blood Sugar)
- Lipid Profile
- Vitamin D (25-Hydroxy)
- Urine R/M (Urine Routine & Microscopy)
- Coronavirus Covid -19 test- RT PCR
- LFT (Liver Function Test)
- KFT (Kidney Function Test)
- TSH (Thyroid Stimulating Hormone) Ultrasensitive
- ESR (Erythrocyte Sedimentation Rate)
- Uric Acid, Serum
- Vitamin B12
- CRP (C-Reactive Protein), Quantitative
- Urine C/S (Urine Culture and Sensitivity)
- Serum Electrolytes
- Serum Calcium
- Serum Creatinine
- Diabetes Screening (HbA1C & Fasting Sugar)
- KFT with Electrolytes (Kidney Function Test with Electrolytes)
- Cholesterol - Total
- Hb (Hemoglobin)
- Complete Hemogram (CBC & ESR)








